Alzheimer’s Treatment: Dichlorophenyl Oxadiazole
Tech ID
P27-1239
Patent Status
Granted in India
Design Status
--
Technical Description
The present invention provides a novel multifunctional hybrid molecule for the treatment of neurodegenerative diseases. It is a hybrid of N-benzylpiperidine and 5-(2,4-dichlorophenyl)-1,3,4-oxadiazole for the treatment of Alzheimer’s disease
Problems Addressed
- Aβ Accumulation in Brain
- Decreased Cholinergic Activity
- Limitations of Existing Treatments
- Monofunctional Molecules
TARGET AUDIENCE
- Healthcare & Medical Sector
- Pharmaceutical Industry
- Biotechnology Firms
- Research and Development
TECH FEATURES
- Multifunctional Molecules
- Inhibits Cholinesterases & BACE-1
- High Melting Point
- Low IC50 Value
- Novel Compound
- Anti-Aβ Aggregation Activity
- Low Toxicity
P27-1239
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com